Free Trial

LifeMD (LFMD) Competitors

LifeMD logo
$5.80 +0.11 (+1.93%)
(As of 11/22/2024 ET)

LFMD vs. SMED, RGS, AIH, MRM, CSTL, AGL, INNV, GRAL, SHCR, and AUNA

Should you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Sharps Compliance (SMED), Regis (RGS), Aesthetic Medical International Holdings Group (AIH), MEDIROM Healthcare Technologies (MRM), Castle Biosciences (CSTL), agilon health (AGL), InnovAge (INNV), Grail (GRAL), Sharecare (SHCR), and Auna (AUNA).

LifeMD vs.

LifeMD (NASDAQ:LFMD) and Sharps Compliance (NASDAQ:SMED) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends, community ranking and institutional ownership.

35.5% of LifeMD shares are held by institutional investors. Comparatively, 56.1% of Sharps Compliance shares are held by institutional investors. 16.0% of LifeMD shares are held by company insiders. Comparatively, 4.8% of Sharps Compliance shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Sharps Compliance has lower revenue, but higher earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than Sharps Compliance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$152.55M1.65-$20.60M-$0.64-9.06
Sharps Compliance$76.42M2.22$12.87M$0.3128.23

LifeMD presently has a consensus target price of $12.00, suggesting a potential upside of 106.90%. Given LifeMD's stronger consensus rating and higher probable upside, equities analysts clearly believe LifeMD is more favorable than Sharps Compliance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeMD
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
Sharps Compliance
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, LifeMD had 2 more articles in the media than Sharps Compliance. MarketBeat recorded 2 mentions for LifeMD and 0 mentions for Sharps Compliance. LifeMD's average media sentiment score of 1.17 beat Sharps Compliance's score of 0.00 indicating that LifeMD is being referred to more favorably in the media.

Company Overall Sentiment
LifeMD Positive
Sharps Compliance Neutral

Sharps Compliance received 207 more outperform votes than LifeMD when rated by MarketBeat users. However, 75.56% of users gave LifeMD an outperform vote while only 49.49% of users gave Sharps Compliance an outperform vote.

CompanyUnderperformOutperform
LifeMDOutperform Votes
34
75.56%
Underperform Votes
11
24.44%
Sharps ComplianceOutperform Votes
241
49.49%
Underperform Votes
246
50.51%

Sharps Compliance has a net margin of 7.88% compared to LifeMD's net margin of -12.06%. Sharps Compliance's return on equity of 5.48% beat LifeMD's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeMD-12.06% N/A -36.34%
Sharps Compliance 7.88%5.48%3.71%

LifeMD has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500. Comparatively, Sharps Compliance has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500.

Summary

Sharps Compliance beats LifeMD on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFMD vs. The Competition

MetricLifeMDOffices & clinics of medical doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$251.20M$1.03B$5.38B$8.84B
Dividend YieldN/AN/A5.13%4.09%
P/E Ratio-9.0611.51105.1417.83
Price / Sales1.651.501,233.15158.41
Price / CashN/A43.0440.4136.29
Price / Book-41.433.337.096.50
Net Income-$20.60M-$52.07M$119.65M$226.22M
7 Day Performance5.74%2.52%2.25%4.03%
1 Month Performance32.12%-1.07%-2.33%4.92%
1 Year Performance-15.82%-4.28%33.98%29.30%

LifeMD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFMD
LifeMD
2.3837 of 5 stars
$5.80
+1.9%
$12.00
+106.9%
-15.8%$251.20M$152.55M-9.06230Positive News
SMED
Sharps Compliance
N/A$8.75
flat
N/A+0.0%$170.01M$76.42M28.23190
RGS
Regis
1.5468 of 5 stars
$21.41
+12.4%
N/A+230.1%$48.82M$202.98M0.58275
AIH
Aesthetic Medical International Holdings Group
N/AN/AN/AN/A$15.93M$682.59M0.001,286Gap Down
MRM
MEDIROM Healthcare Technologies
N/A$2.88
-0.3%
N/A-43.3%$14.52M$48.70M0.001,101
CSTL
Castle Biosciences
3.3866 of 5 stars
$28.88
+1.5%
$37.88
+31.1%
+50.2%$808.93M$219.79M144.41540Insider Trade
AGL
agilon health
2.2739 of 5 stars
$1.78
+6.6%
$6.05
+239.9%
-84.0%$733.40M$4.32B-1.891,117Analyst Forecast
INNV
InnovAge
1.4796 of 5 stars
$4.63
-1.5%
$6.50
+40.4%
-11.7%$627.18M$763.85M-37.922,350
GRAL
Grail
0.3082 of 5 stars
$16.38
+8.5%
N/AN/A$550.37MN/A0.001,360Insider Trade
SHCR
Sharecare
N/A$1.43
flat
$1.43
N/A$531.79M$445.25M-3.673,352
AUNA
Auna
3.8446 of 5 stars
$7.12
+1.1%
$13.40
+88.2%
N/A$526.31M$1.04B0.0014,958News Coverage

Related Companies and Tools


This page (NASDAQ:LFMD) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners